His study in Adiponectin receptor 1 extends to Endocrinology with its themes. Toshimasa Yamauchi combines topics linked to Insulin with his work on Adiponectin receptor 1. His Insulin study frequently involves adjacent topics like Insulin receptor. Toshimasa Yamauchi integrates Insulin receptor and Insulin resistance in his research. He performs multidisciplinary study on Insulin resistance and Type 2 diabetes in his works. Toshimasa Yamauchi conducted interdisciplinary study in his works that combined Type 2 diabetes and Diabetes mellitus. His Metabolic syndrome research extends to Diabetes mellitus, which is thematically connected. Toshimasa Yamauchi conducts interdisciplinary study in the fields of Metabolic syndrome and Adiponectin through his research. In his research, he undertakes multidisciplinary study on Adiponectin and Adipocyte.
His Endocrinology study frequently draws connections between adjacent fields such as Type 2 diabetes. Toshimasa Yamauchi performs integrative Type 2 diabetes and Insulin resistance research in his work. His multidisciplinary approach integrates Insulin resistance and Obesity in his work. In most of his Obesity studies, his work intersects topics such as Endocrinology. His Internal medicine study typically links adjacent topics like Receptor. Toshimasa Yamauchi regularly ties together related areas like Peroxisome proliferator-activated receptor in his Receptor studies. His Peroxisome proliferator-activated receptor study frequently links to related topics such as Internal medicine. His research brings together the fields of Insulin receptor and Insulin. Insulin receptor is closely attributed to Insulin in his research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
T. Yamauchi;J. Kamon;H. Waki;Y. Terauchi.
Nature Medicine (2001)
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
T Yamauchi;J Kamon;Y Minokoshi;Y Ito.
Nature Medicine (2002)
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
Toshimasa Yamauchi;Junji Kamon;Yusuke Ito;Atsushi Tsuchida.
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Takashi Kadowaki;Toshimasa Yamauchi;Naoto Kubota;Kazuo Hara.
Journal of Clinical Investigation (2006)
Adiponectin and Adiponectin Receptors
Takashi Kadowaki;Toshimasa Yamauchi.
Endocrine Reviews (2005)
Disruption of adiponectin causes insulin resistance and neointimal formation.
Naoto Kubota;Yasuo Terauchi;Toshimasa Yamauchi;Tetsuya Kubota.
Journal of Biological Chemistry (2002)
PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance
Naoto Kubota;Yasuo Terauchi;Hiroshi Miki;Hiroyuki Tamemoto;Hiroyuki Tamemoto.
Molecular Cell (1999)
Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions.
Toshimasa Yamauchi;Yasunori Nio;Toshiyuki Maki;Masaki Kobayashi.
Nature Medicine (2007)
Impaired Multimerization of Human Adiponectin Mutants Associated with Diabetes MOLECULAR STRUCTURE AND MULTIMER FORMATION OF ADIPONECTIN
Hironori Waki;Toshimasa Yamauchi;Junji Kamon;Yusuke Ito.
Journal of Biological Chemistry (2003)
Globular Adiponectin Protected ob/ob Mice from Diabetes and ApoE-deficient Mice from Atherosclerosis
Toshimasa Yamauchi;Junji Kamon;Hironori Waki;Yasushi Imai.
Journal of Biological Chemistry (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: